TFF Pharmaceuticals, Inc. Common Stock
TFFP
TFFP was delisted on the 12th of December, 2024.
36 hedge funds and large institutions have $4.79M invested in TFF Pharmaceuticals, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 12 increasing their positions, 7 reducing their positions, and 8 closing their positions.
1,933% more call options, than puts
Call options by funds: $61K | Put options by funds: $3K
71% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 7
12% less funds holding
Funds holding: 41 → 36 (-5)
39% less capital invested
Capital invested by funds: $7.84M → $4.79M (-$3.05M)
63% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GS
Gagnon Securities
New York
|
+$138K |
| 2 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
+$47.1K |
| 3 |
CC
Carlson Capital
Dallas,
Texas
|
+$32.9K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$13.6K |
| 5 |
BlackRock
New York
|
+$11.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Sepio Capital
Salt Lake City,
Utah
|
-$347K |
| 2 |
Two Sigma Investments
New York
|
-$39.8K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$38.6K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$30.2K |
| 5 |
FA
Fermata Advisors
Sonoma,
California
|
-$30K |
TFFP Hedge Fund Activity: Q1 2023 in Review
36 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in TFF Pharmaceuticals, Inc. Common Stock (TFFP) for Q1 2023, worth a combined $4.79M — down 39% from $7.84M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of TFFP and 3 opened new positions — a net loss of 5 holders — while 7 trimmed existing stakes and 12 added.
The largest buyer was Gagnon Securities, adding an estimated $138K. The largest seller was Sepio Capital, exiting entirely with an estimated $347K sold.
- 36 institutional investors held TFF Pharmaceuticals, Inc. Common Stock (TFFP) as of Q1 2023, down from 41 in Q4 2022.
- Funds reported $4.79M of TFF Pharmaceuticals, Inc. Common Stock stock for Q1 2023, down 39% quarter-over-quarter.
- 3 funds opened new TFF Pharmaceuticals, Inc. Common Stock positions in Q1 2023 and 8 closed out, a net change of -5 holders.
- The largest TFF Pharmaceuticals, Inc. Common Stock buyer in Q1 2023 was Gagnon Securities, an estimated $138K added.
- The largest TFF Pharmaceuticals, Inc. Common Stock seller in Q1 2023 was Sepio Capital, an estimated $347K sold.
Based on aggregated 13F filings for Q1 2023.